These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 7681990)

  • 1. Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase.
    Richter W; Shi Y; Baekkeskov S
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2832-6. PubMed ID: 7681990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune reactivity of diabetes-associated human monoclonal autoantibodies defines multiple epitopes and detects two domain boundaries in glutamate decarboxylase.
    Syren K; Lindsay L; Stoehrer B; Jury K; Lühder F; Baekkeskov S; Richter W
    J Immunol; 1996 Dec; 157(11):5208-14. PubMed ID: 8943434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine monoclonal glutamic acid decarboxylase (GAD)65 antibodies recognize autoimmune-associated GAD epitope regions targeted in patients with type 1 diabetes mellitus and stiff-man syndrome.
    Ziegler B; Schlosser M; Lühder F; Strebelow M; Augstein P; Northemann W; Powers AC; Ziegler M
    Acta Diabetol; 1996 Sep; 33(3):225-31. PubMed ID: 8904930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of epitope recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different autoimmune disorders.
    Powers AC; Bavik K; Tremble J; Daw K; Scherbaum WA; Banga JP
    Clin Exp Immunol; 1999 Dec; 118(3):349-56. PubMed ID: 10594551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes.
    Tremble J; Morgenthaler NG; Vlug A; Powers AC; Christie MR; Scherbaum WA; Banga JP
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2664-70. PubMed ID: 9253351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of glutamic acid decarboxylase autoantibody heterogeneity and epitope regions in type I diabetes.
    Ujihara N; Daw K; Gianani R; Boel E; Yu L; Powers AC
    Diabetes; 1994 Aug; 43(8):968-75. PubMed ID: 8039604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the islet cell antibody pattern of monoclonal glutamic acid decarboxylase antibodies recognizing linear and conformational epitopes.
    Augstein P; Schlosser M; Ziegler B; Hahmann J; Mauch L; Ziegler M
    Acta Histochem; 1996 Apr; 98(2):229-41. PubMed ID: 8739307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human monoclonal islet cell antibodies from a patient with insulin-dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen.
    Richter W; Endl J; Eiermann TH; Brandt M; Kientsch-Engel R; Thivolet C; Jungfer H; Scherbaum WA
    Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8467-71. PubMed ID: 1382289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-resolution autoreactive epitope mapping and structural modeling of the 65 kDa form of human glutamic acid decarboxylase.
    Schwartz HL; Chandonia JM; Kash SF; Kanaani J; Tunnell E; Domingo A; Cohen FE; Banga JP; Madec AM; Richter W; Baekkeskov S
    J Mol Biol; 1999 Apr; 287(5):983-99. PubMed ID: 10222205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A monoclonal antibody-based characterization of autoantibodies against glutamic acid decarboxylase in adults with latent autoimmune diabetes.
    Ziegler B; Strebelow M; Rjasanowski I; Schlosser M; Ziegler M
    Autoimmunity; 1998; 28(2):61-8. PubMed ID: 9771977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of an autoreactive epitope within glutamate decarboxylase using a diabetes-associated human monoclonal autoantibody and an epitope cDNA library.
    Richter W; Northemann W; Müller M; Böhm BO
    Hybridoma; 1996 Apr; 15(2):103-8. PubMed ID: 8743289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus.
    Kim J; Namchuk M; Bugawan T; Fu Q; Jaffe M; Shi Y; Aanstoot HJ; Turck CW; Erlich H; Lennon V; Baekkeskov S
    J Exp Med; 1994 Aug; 180(2):595-606. PubMed ID: 7519242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity in the occurrence of a subset of autoantibodies to glutamic acid decarboxylase in autoimmune polyendocrine patients with islet cell antibodies.
    Davenport C; Radford PM; Al-Bukhari TA; Lai M; Bottazzo GF; Todd I
    Clin Exp Immunol; 1998 Mar; 111(3):497-505. PubMed ID: 9528889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamic acid decarboxylase-67 (GAD67): expression relative to GAD65 in human islets and mapping of autoantibody epitopes.
    Cram DS; Faulkner-Jones B; Kun J; Harrison LC
    Endocrinology; 1995 Mar; 136(3):1111-9. PubMed ID: 7532577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human monoclonal islet specific autoantibodies share features of islet cell and 64 kDa antibodies.
    Richter W; Eiermann TH; Endl J; Seissler J; Wolfahrt S; Brandt M; Jungfer H; Scherbaum WA
    Diabetologia; 1993 Aug; 36(8):785-90. PubMed ID: 7691667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered variants of human glutamic acid decarboxylase (GAD) and autoantibody epitope recognition.
    Primo ME; Anton EA; Villanueva AL; Poskus E; Ermácora MR
    Clin Immunol; 2003 Jul; 108(1):38-45. PubMed ID: 12865069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COOH-terminal clustering of autoantibody and T-cell determinants on the structure of GAD65 provide insights into the molecular basis of autoreactivity.
    Fenalti G; Hampe CS; Arafat Y; Law RH; Banga JP; Mackay IR; Whisstock JC; Buckle AM; Rowley MJ
    Diabetes; 2008 May; 57(5):1293-301. PubMed ID: 18184926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic determinants to GAD autoantibodies in patients with type 1 diabetes with and without autoimmune thyroid disease.
    Park H; Yu L; Kim T; Cho B; Kang J; Park Y
    Ann N Y Acad Sci; 2006 Oct; 1079():213-9. PubMed ID: 17130557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of amino-terminal-specific antiglutamate decarboxylase (GAD65) autoantibodies with beta-cell functional reserve and a milder clinical phenotype in patients with GAD65 antibodies and ketosis-prone diabetes mellitus.
    Hampe CS; Nalini R; Maldonado MR; Hall TR; Garza G; Iyer D; Balasubramanyam A
    J Clin Endocrinol Metab; 2007 Feb; 92(2):462-7. PubMed ID: 17090641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of GAD65 and GAD67 in human, rat, and mouse pancreatic islets.
    Kim J; Richter W; Aanstoot HJ; Shi Y; Fu Q; Rajotte R; Warnock G; Baekkeskov S
    Diabetes; 1993 Dec; 42(12):1799-808. PubMed ID: 8243826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.